Two 16-week TB regimens advance after phase II trial
Health · Friday, November 20, 2026 · 10 sources

Two 16-week TB regimens advance after phase II trial

A phase II trial of 401 adults with rifampin-susceptible pulmonary tuberculosis identified two 16-week drug combinations for further testing, compared with the standard 24-week regimen. In the New England Journal of Medicine study, the combinations cleared bacteria faster on an early sputum test, but researchers say treatment duration and protection against relapse still need testing.

Bottom line — Both combinations move to the next PARADIGM4TB stage; phase III trials would still be needed before they could reach patients.

Go deeper 6

  1. The BTZ-043 combination had a 99% probability of outperforming standard treatment on the early clearance measure; the ganfeborole combination had an 83% probability, according to the trial results.

  2. At week 48, favourable outcomes were recorded for 93% of the BTZ-043 group, 80% of the ganfeborole group and 89% of the standard-treatment group.

  3. Severe adverse events affected 28% of the BTZ-043 group and 38% of the ganfeborole group, compared with 24% receiving standard treatment.

  4. Medical Xpress reports that a different BTZ-043 combination, which included pyrazinamide, showed excess liver toxicity.

  5. The trial’s lead investigators say the next stage will test how short each treatment can be while still preventing relapse.

  6. Eric Rubin, writing in an accompanying editorial, cautioned that faster clearance in sputum cultures may not capture the smaller bacterial populations that can survive treatment.

Read the reporting 10

dstld. Your daily news summary designed to surface the news that matters from a European perspective. Curated by humans, summarized by AI - always with links back to the original reporting.

Links · Contact
Popular topics · WorldEuropeGamesAI
Last generated: Nov 20, 7:25 PM UTC by wreetco

dstld. Your daily news summary designed to surface the news that matters from a European perspective. Curated by humans, summarized by AI - always with links back to the original reporting.

Links · Contact
Popular topics · WorldEuropeGamesAI
Last generated: Nov 20, 7:25 PM UTC by wreetco